Cardiopulmonary Function and Cerebral Blood Flow in Hodgkin Lymphoma Survivors

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

SURVIVORS Study participants are being asked to take part in this research study called HODNIRS because the participant is a survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital. The study is being done to help investigators understand the link between long term effects of chest radiation and bleomycin for HL and brain function in survivors. Primary Objective To evaluate dynamic changes in CBF and oxygenation during exercise with Near Infrared Spectroscopy (NIRS) in HL survivors and non-cancer controls matched for age, sex, race, and ethnicity. . Secondary Objectives To examine the degree of CO2 clearance (DLCO/ETCO2) during rest and exercise in Hodgkin Lymphoma (HL) survivors compared to non-cancer controls matched for age, sex, race, and ethnicity. CONTROLS Volunteers are being asked to take part in this research study because they are non-first degree relative or friend of someone who received treatment for a childhood cancer or similar illness at St. Jude Children's Research Hospital or are an employee/affiliate of St. Jude Children's Research Hospital and have agreed to be a St. Jude Life Cohort Study (SJLIFE) community control.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ HL Survivors

• Completed bleomycin and/or thoracic radiation therapy for HL at SJCRH.

• \<21-years old at diagnosis; currently ≥18-years of age and ≥2-years post therapy.

• SJLIFE or ACT/SJLIFE participants

• English language proficiency.

⁃ Community Controls

• SJLIFE control.

• ≥18-years of age at the time of enrollment with age sampling to broadly match the HL survivors.

Locations
United States
Tennessee
St. Jude Children's Research Hospital
RECRUITING
Memphis
Contact Information
Primary
Nicholas Phillips, PhD
referralinfo@stjude.org
866-278-5833
Time Frame
Start Date: 2024-05-06
Estimated Completion Date: 2027-03
Participants
Target number of participants: 100
Treatments
SURVIVOR
A survivor of Hodgkin Lymphoma (HL) treated with chest radiation and bleomycin at St. Jude Children's Research Hospital.~and Control: Voluntarily taking part in this study because you are a relative, friend or employee of St. Jude Children's Research Hospital.
Related Therapeutic Areas
Sponsors
Leads: St. Jude Children's Research Hospital

This content was sourced from clinicaltrials.gov